Fortitude Family Office »

Aerovate Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-03-31 $12k 416 29.57
2023-12-31 $9.4k 416 22.63

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Jpmorgan Ultra-short Income Etf Ultra Short Income Fund Etf (JPST)
Kkr & Co Stock (KKR)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Vanguard Ftse Emerging Markets Etf Etf (VWO)

View all positions for Fortitude Family Office

Top funds holding Aerovate Therapeutics

RA Capital Management
Atlas Venture Life Science Advisors
Baker Bros. Advisors
Cormorant Asset Management
Frazier Life Sciences Management
Dr. Jeffrey R. Jay, M.D.
OrbiMed Advisors
Vanguard Group
Point72 Asset Management
Octagon Capital Advisors
Paradigm Biocapital Advisors
Hudson Bay Capital Management
Nantahala Capital Management
Fred Alger Management
Charles Schwab Investment Management

View all funds holding Aerovate Therapeutics